Last reviewed · How we verify

NCT05611580

Rural Chronic Disease Risk Reduction

Completed NA Last updated 4 July 2025
What this trial tests

NA trial testing Chronic Disease Risk Reduction in Chronic Disease in 80 participants. Completed in 31 May 2024.

Timeline
1 January 2023
Primary endpoint
31 May 2024
31 May 2024

Quick facts

Lead sponsorFlorida State University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment80
Start date1 January 2023
Primary completion31 May 2024
Estimated completion31 May 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Florida State University

Who can join

18 and older, any sex, with Chronic Disease or Risk Reduction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study tests a web-based chronic disease risk reduction lifestyle medicine intervention among rural adults.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effects of a Group-Based Online Lifestyle Medicine Intervention Among Rural Participants: A Randomized Controlled Trial.
    Abbott LS, Killian M, Butts B, Graven LJ. · · 2025 · PMID 41210077 · DOI 10.1177/15598276251395532

Verify or expand the search:

Other recruiting trials for Chronic Disease

Currently open trials in the same condition.

Other Florida State University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05611580.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing